Industry Symposium 43

30 Mar 2026 12:50 p.m. 1:50 p.m.
315
AshokSarin Chair India

Session Title: Reimagining Anemia Management in CKD: Evolution with HIF-PHIs

Theme: Preserving Kidney Health

Organized By: Zydus LifeSciences

Session Description:

In recent times, the optimal CKD management has evolved with the advent of HIF-PHIs.

In India, currently, Desidustat is the only HIF-PHI marketed and available for clinical usage. Since its availability, tens of thousands of Indian patients of CKD and identifying the most suitable patient profiles. Newer evidence also suggests a possible role of this new class of drugs beyond anemia

This symposium reviews the evolving role of CKD anemia management in the era of HIF PHIs with Real-World Experience from India.
 
Learning Objectives:
  1. Understand how HIF-PHIs work and why treatment is shifting from ESAs to HIF-PHIs.
  2. Review key clinical and real-world evidence for Desidustat and other HIF-PHIs.
  3. Apply practical guidance on patient selection, initiation, and monitoring for Desidustat/HIF-PHIs 
Time Session
12:50 p.m.
1:05 p.m.
Paradigm Shift in Anemia Management: From ESAs to HIF-PHIs
Prem PrakashVarma Speaker varmapp123@rediffmail.comIndia
1:05 p.m.
1:20 p.m.
Real World Evidence with Desidustat: India's Contribution to the Global HIF Story
DineshKhullar Speaker drdineshkhullar@gmail.comIndia
1:20 p.m.
1:50 p.m.
Panel discussion - Optimizing Outcomes with HIF-PHIs in CKD Anemia
ManishMalik Moderator navyaanshumanish@gmail.comIndia
Narayan Prasad Panel narayan.nephro@gmail.comIndia
SandipBhattacharya Panel sandipkb65@gmail.comIndia
DibyaSingh Shah Panel dibyasingh@hotmail.comNepal
D SBhadauria Panel speaker@doc.comIndia